Prevention of acute aspirin-induced gastric mucosal injury by 15-R-15 methyl prostaglandin E2: An endoscopic study

This publication has 34 references indexed in Scilit:

• Gastric adaptation occurs with aspirin administration in man
  Digestive Diseases and Sciences, 1983
• Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
  Gut, 1982
• Gastrointestinal Protection by Low-Dose Oral Prostaglandin E₂in Rheumatic Diseases
  Scandinavian Journal of Gastroenterology, 1981
• Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.
  Gut, 1981
• Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin
  Digestive Diseases and Sciences, 1981
• Endoscopic Evaluation of the Effects of Aspirin, Buffered Aspirin, and Enteric-Coated Aspirin on Gastric and Duodenal Mucosa
  New England Journal of Medicine, 1980
• The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy
  Gastrointestinal Endoscopy, 1980
• A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents
  Digestive Diseases and Sciences, 1979
• Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues.
  Gut, 1977
• Effect of Prostaglandin E2 on the Healing of Gastric Ulcers: A Double-Blind Endoscopic Trial
  Australian and New Zealand Journal of Medicine, 1976